Orchestrator Dashboard Overview
Search patients, query agents, or ask AI assistant...

Dashboard Overview

Real-time insights into patient matching and clinical trials

Active Agents

6 Active

Human Verification Center

5 Cases

Protocol Conflict: Trial #0921

Agent 'OncoMatch' detected exclusion criteria overlap with patient MBPT-8921's renal function.

Contradiction Alert: MBPT-3321

Patient medication (Warfarin) contradicts with trial NCT099123 requirements.

Missing Data: MBPT-5512

Cytogenetic test results pending. Cannot proceed with matching.

Age Verification: Trial #1823

Patient age (78) is at upper boundary. Manual approval required.

Prior Treatment Conflict

MBPT-9911 has received CAR-T therapy. Trial requires treatment-naive patients.

Patient Pipeline (Oncology)

Patient Profile
Current Therapy
Next Line
Progression
Action

Analytics Dashboard

Real-time patient funnel and global provider insights

Filter Patients by Clinical Attributes

Patient Distribution by State

No states match the selected filters

Provider Distribution

Provider network across United States

Total: Providers

Summary

Total Patients

Updated in last 24 hours

Active States

Updated in last 24 hours

Avg per State

Updated in last 24 hours

Top 5 States

No states to display

Live Activity

Live

New Patient Added

MBPT-8821 • Cholangiocarcinoma

San Francisco, CA • Just now

Match Completed

MBPT-3321 • 4 trials matched

Seattle, WA • 2 min ago

Provider Connected

Memorial Sloan Kettering

New York, NY • 5 min ago

RWE Cohort Built

NSCLC Stage IV • 234 patients

Boston, MA • 8 min ago

DUO Analysis Complete

Drug X efficacy study • 12 sites

Houston, TX • 12 min ago

Agent Orchestrator

Real-time supervision of the autonomous patient data pipeline

System Status: Operational • Active Threads: 142

Live Pipeline

Throughput

Latency

Active Agents in this Stage

Deploy Agent

Add a new worker to the stage

Clinical Trials Portfolio

AI-powered trial management with real-time patient matching and site intelligence

Active

Active Protocols

+24%

2,847

Eligible Patients

312 Sites

78

Partner Institutions

94.2%

87%

Enrollment Rate

Add New Trial

Import protocol PDF or enter details manually

AZURE A/B TESTING ML MODEL

• •

Status Overview

Current Status

Uptime

Deployment

Auto-Scale

Performance Metrics

Agent Capabilities

Machine Learning Model Details

Model Architecture

BERT-Large

Parameters

340M

Training Data

1.2M records

Performance Metrics

Precision 96.2%
Recall 94.8%
F1 Score 95.5%

Version Management

Current Version

STABLE

v5.1.1

Available for update

v5.2.0-beta

Beta testing

Version History

v5.1.0 Dec 15, 2025 Performance
v5.0.2 Nov 28, 2025 Bug Fixes
v5.0.0 Nov 10, 2025 Major Update

Model Drift Detection

Concept Drift

0.8%

Within acceptable range

Data Drift

2.1%

Monitoring

Last Retrained

14d ago

Scheduled: 7d

Drift Alerts

Model performance remains stable. No immediate retraining required.

Recent Activity Log

Health Check

All systems operational, latency: 42ms

1 hour ago

Daily Maintenance

Cache cleared, logs rotated, backup completed

3 hours ago

Quick Actions

Resource Utilization

CPU Usage
Memory Usage
Network I/O 142 MB/s
Active Threads 24
Queue Depth
Error Rate 0.3%

Connected Services

PostgreSQL
Redis Cache
Azure Blob
EHR API

⚠️ Human Verification Needed

AI system requires your decision

Patient: •

Human Verification Required

AI system requires human decision for patient matching

Patient Information

Patient ID

Patient Name

Timestamp

Trial ID

NCT099123

Issue Detected

AI Analysis & Failure Point

AI Agent: Medical Record Engaging Agent

Analysis Details:

Confidence Score: 68%
Threshold: 85%
Failure Reason: Below confidence threshold
Conflicting Medications: Warfarin

⚠️ Trial Protocol Requirement

Patients must not be on anticoagulation therapy due to increased bleeding risk with investigational agent.

AI Recommended Action

Recommendation: Exclude patient from trial unless Warfarin can be safely discontinued and replaced with alternative therapy.

Alternative Consideration: Patient may be eligible if switched to direct thrombin inhibitor with shorter half-life and trial protocol amended.

Patients Registry

Comprehensive patient management with journey tracking and advanced filtering

Total

Patients

Active

In Treatment

Trials

Trial Eligible

Urgent

Needs Review

Patient Journey Pipeline

Showing distribution across journey stages

Filter Patients

Patient Registry

Showing - of
Patient ID
Condition
Current Therapy
Line
Next Therapy
Progression
Actions

No patients found

Try adjusting your filters

Page of
Powered by Reticulum Nexus

DOB: 12/04/1958 ID:

Cohort Based Percentile Survival Model

Threshold 100% 75% 50% 25% 0% 0m 6m 12m 18m 24m

Disease Progression

Progression on First Line Therapy

2 weeks ago

Patient showed resistance to Lenalidomide. M-protein levels increased by 15%.

Initial Diagnosis: Multiple Myeloma

14 months ago

Stage II ISS. Cytogenetics: t(4;14).

AI Matched Trials

98% Match
Phase 3: CAR-T Therapy vs SOC

NCT045621 • Recruiting • 12mi away

Provenance & Traceability

EHR Data Ingestion

Dec 20, 2025 14:23

Source: Epic EMR System v2024.1

AI Matching Execution

Dec 20, 2025 14:25

Model: OncoMatch_v4.1.2

Recommended Next Action

Patient Outreach

Schedule follow-up call to discuss trial options

AI Analysis
Eligibility Confidence 92%

Clinical Diagnosis

Primary Condition

Stage

Diagnosed

Oct 2024

Performance Status (ECOG)

Score: 1

Molecular Profile

No biomarker data available.

Medication History

Drug Name Dosage Frequency Start Date Status

Surgical & Procedural History

Document viewer is restricted in this demo.

Add New Patient

Enter patient information to add them to the registry

Basic Information

Clinical Information

Biomarkers (Optional)

Suggested Queries

Reticulum Agent is analyzing 154 protocols...

I found 3 matching protocols for high-risk Myeloma.

Based on your query, the following trials have opened recruitment in the last 7 days and match the standard exclusion criteria for patients with renal impairment.

Ph 2

NCT044922: Anti-BCMA CAR-T

Massive Bio Network • 2 Sites available

Add Clinical Trial

Import a new protocol to the Reticulum portfolio

Parameterizing Protocol...

Upload Protocol Document

Drag and drop your PDF here, or click to browse.
Reticulum AI will extract criteria automatically.

PDF DOCX XML

Create New AI Agent

Configure your agent's capabilities, data sources, and behavior

Basic Configuration

Define your agent's core identity and purpose

Data Source Connections

Connect your agent to EHR systems and data sources

EHR Systems

Third-Party Connectors

Custom API Connection

LLM Context & Capabilities

Define your agent's behavior, reasoning patterns, and capabilities

Agentic Design Patterns

System Prompt

Define the agent's role, behavior, and constraints.

Context Window Size

tokens
1K 8K 16K 32K 128K

Agent Capabilities

Review & Create

Review your agent configuration before deployment

Basic Info
Name:
Category:
Model:
Data Sources
Connected Sources:
No external sources selected.
LLM Configuration
Patterns:
Context Window:
Capabilities:
Requirements
Deployment Configuration

Compute Tier

Auto-scaling

Estimated Cost

Latency